STREAMEX CORP (STEX) Fundamental Analysis & Valuation
NASDAQ:STEX • US09073N3008
Current stock price
1.59 USD
-0.12 (-7.02%)
At close:
1.67 USD
+0.08 (+5.03%)
After Hours:
This STEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. STEX Profitability Analysis
1.1 Basic Checks
- STEX had negative earnings in the past year.
- In the past year STEX has reported a negative cash flow from operations.
- STEX had negative earnings in each of the past 5 years.
- STEX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- STEX has a Return On Assets (-30.57%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.57% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-1175.93%
ROA(5y)-781.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- STEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. STEX Health Analysis
2.1 Basic Checks
- STEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- STEX has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, STEX has more shares outstanding
- There is no outstanding debt for STEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -3.61, we must say that STEX is in the distress zone and has some risk of bankruptcy.
- STEX's Altman-Z score of -3.61 is on the low side compared to the rest of the industry. STEX is outperformed by 67.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.61 |
ROIC/WACCN/A
WACC10.28%
2.3 Liquidity
- STEX has a Current Ratio of 0.12. This is a bad value and indicates that STEX is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.12, STEX is not doing good in the industry: 96.20% of the companies in the same industry are doing better.
- STEX has a Quick Ratio of 0.12. This is a bad value and indicates that STEX is not financially healthy enough and could expect problems in meeting its short term obligations.
- STEX's Quick ratio of 0.12 is on the low side compared to the rest of the industry. STEX is outperformed by 95.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.12 | ||
| Quick Ratio | 0.12 |
3. STEX Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 80.81% over the past year.
- Looking at the last year, STEX shows a very negative growth in Revenue. The Revenue has decreased by -63.89% in the last year.
- STEX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -55.07% yearly.
EPS 1Y (TTM)80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-289.42%
Revenue 1Y (TTM)-63.89%
Revenue growth 3Y-55.07%
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- STEX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.81% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y68.52%
EPS Next 2Y40.08%
EPS Next 3Y37.81%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. STEX Valuation Analysis
4.1 Price/Earnings Ratio
- STEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STEX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as STEX's earnings are expected to grow with 37.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.08%
EPS Next 3Y37.81%
5. STEX Dividend Analysis
5.1 Amount
- No dividends for STEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
STEX Fundamentals: All Metrics, Ratios and Statistics
1.59
-0.12 (-7.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2025-11-14
Earnings (Next)04-13 2026-04-13/amc
Inst Owners14.98%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner Change23.28%
Market Cap283.85M
Revenue(TTM)13.00K
Net Income(TTM)-39.89M
Analysts82.86
Price Target12.24 (669.81%)
Short Float %5.73%
Short Ratio2.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 21834.37 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS-0.04
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.57% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-1175.93%
ROA(5y)-781.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.12 | ||
| Quick Ratio | 0.12 | ||
| Altman-Z | -3.61 |
F-Score3
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)36.29%
Cap/Depr(5y)95.03%
Cap/Sales(3y)364.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-289.42%
EPS Next Y68.52%
EPS Next 2Y40.08%
EPS Next 3Y37.81%
EPS Next 5YN/A
Revenue 1Y (TTM)-63.89%
Revenue growth 3Y-55.07%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y114.46%
EBIT Next 5Y121.73%
FCF growth 1Y57.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.3%
OCF growth 3YN/A
OCF growth 5YN/A
STREAMEX CORP / STEX Fundamental Analysis FAQ
What is the ChartMill fundamental rating of STREAMEX CORP (STEX) stock?
ChartMill assigns a fundamental rating of 0 / 10 to STEX.
What is the valuation status for STEX stock?
ChartMill assigns a valuation rating of 1 / 10 to STREAMEX CORP (STEX). This can be considered as Overvalued.
Can you provide the profitability details for STREAMEX CORP?
STREAMEX CORP (STEX) has a profitability rating of 0 / 10.
Can you provide the financial health for STEX stock?
The financial health rating of STREAMEX CORP (STEX) is 0 / 10.